Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma. Read more about Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.
INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Read more about INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. Read more about Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis.
Understanding TERT Promoter Mutations: A Common Path to Immortality. Read more about Understanding TERT Promoter Mutations: A Common Path to Immortality.
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. Read more about BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer.
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts. Read more about Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53. Read more about Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.
TGFβ1 protects cells from γ-IR by enhancing the activity of the NHEJ repair pathway. Read more about TGFβ1 protects cells from γ-IR by enhancing the activity of the NHEJ repair pathway.
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Read more about The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection. Read more about Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.
